Remote Patient Monitoring System Market to Account for $4.1 Billion by 2028: Grand View Research Inc.

 

Remote Patient Monitoring System Market Growth & Trends

The global remote patient monitoring system market size is expected to reach USD 4.1 billion by 2028, according to a new report by Grand View Research Inc. It is expected to expand at a CAGR of 19.7% from 2021 to 2028. The remote patient monitoring (RPM) system uses digital technology to gather patient data and monitor a patient’s health remotely. The remote patient monitoring system is expected to witness substantial growth in demand due to its capability to monitor various chronic conditions, such as diabetes, cardiovascular conditions, and cancer.

According to the Centers for Disease Control and Prevention (CDC), 34.2 million people in the U.S. have diabetes and 88 million have prediabetes. Apart from this, the World Health Organization (WHO) estimates that around 422 million people have diabetes at the global level. Companies are consistently engaged in developing tools for monitoring patients with diabetes and other chronic diseases outside of conventional care settings, especially during the COVID-19 pandemic fueling the market growth.

Asia Pacific is projected to be a key revenue-generating region in the coming years. The region is backed by developing countries, such as China, South Korea, and Thailand, which are witnessing an increase in the number of chronic diseases owing to lifestyle changes. Cardiovascular disease is among the leading cause of death in these countries. Remote patient monitoring system is expected to play a key role in the early detection and timely management of these diseases.

Request a free sample copy or view report summary: Remote Patient Monitoring System Market Report

Remote Patient Monitoring System Market Report Highlights

• Based on product, in the specialized monitors segment, cardiac rhythm monitor is expected to expand at a significant CAGR over the forecast period owing to the increasing incidence of cardiac conditions globally
• By end use, home healthcare is projected to be the fastest-growing segment with a CAGR of 20.1% from 2021 to 2028 owing to a rise in the number of patients accessing remote monitoring due to the COVID-19 pandemic
• Asia Pacific is expected to showcase high growth potential in the coming years due to the presence of large unmet needs in emerging economies, such as China and India. This region is also backed by Japan, which has one of the highest numbers of 65+-year-old adults at the global level

Access Press Release of Remote Patient Monitoring System Market@ https://www.grandviewresearch.com/press-release/global-remote-patient-monitoring-devices-market

Remote Patient Monitoring System Market Segmentation

Grand View Research has segmented the global remote patient monitoring system market on the basis of product, application, end-use, and region:

RPM System Product Outlook (Revenue, USD Million, 2016 - 2028)

• Vital Sign Monitors
  • Blood Pressure Monitors
  • Pulse Oximeters
  • Heart Rate Monitor (ECG)
  • Temperature Monitor
  • Respiratory Rate Monitor
  • Brain Monitoring (EEG)
• Specialized Monitors
  • Anesthesia Monitors
  • Blood Glucose Monitors
  • Cardiac Rhythm Monitor
  • Respiratory Monitor
  • Fetal Heart Monitors
  • Prothrombin Monitors
  • Multi Parameter Monitors (MPM)
  • Others

RPM System Application Outlook (Revenue, USD Million, 2016 - 2028)

• Cancer
• Cardiovascular Diseases
• Diabetes
• Sleep Disorder
• Weight management and Fitness Monitoring
• Bronchitis
• Infections
• Virus
• Dehydration
• Hypertension

RPM System End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital Based Patients
• Ambulatory Patients
• Home Healthcare

RPM System Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Thailand
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Remote Patient Monitoring System Market

• Honeywell
• American Telecare
• Roche
• Philips Healthcare
• Bosch
• Biotronik
• Intel
• Welch Allyn
• Health anywhere Inc.
• Johnson & Johnson
• Covidien Plc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Endoscopes Market to Observe Strong Development by 2028| Key participants Karl Storz GmbH & Co. KG; Stryker

 

Endoscopes Market Growth & Trends

The global endoscopes market size is expected to reach USD 19.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.0% from 2021 to 2028. The growing awareness regarding the benefits of minimally invasive surgeries as compared to open invasive surgeries and the rising prevalence of chronic diseases, such as cancer, heart diseases, and diabetes, are some of the factors driving the market. In addition, technological advancements with respect to endoscopes and the increasing applications in various diagnosis and treatment processes are among the key trends boosting the demand for endoscopes globally.

Based on product, flexible endoscopes dominated the market with a share of 49.9% in 2020. This is attributed to the growing preference for such devices among medical professionals, technological advancements, increased efficiency and safety, and ergonomic features of the flexible endoscopes. In addition, these devices are used in numerous procedures, such as upper gastrointestinal endoscopy, colonoscopy, bronchoscopy, sigmoidoscopy, laryngoscopy, pharyngoscopy, duodenoscopy, nasopharyngoscopy, and rhinoscopy, which increase their adoption, thereby fueling the segment growth.

In 2020, based on application, gastrointestinal (GI) endoscopy accounted for the largest revenue share owing to the growing geriatric population and the rising burden of gastrointestinal diseases. In addition, the increase in the number of gastroscopies, the rise in adoption of endoscopes for diagnosis as well as treatment of GI diseases, and the availability of advanced products for gastroscopy are some of the factors driving the segment. In addition, the urology endoscopy segment is expected to expand at the highest CAGR over the forecast period. The growing number of urology surgeries and the increasing prevalence of urologic cancers are among the key factors expected to drive the demand for urology endoscopies.

North America dominated the market with a revenue share of 42.5% in 2020 owing to the improved healthcare infrastructure, the rising adoption of advanced technologies, and the growing preference for minimally invasive surgeries to curb healthcare spending. In addition, the growing burden of gastrointestinal disorders and cancer in the region is one of the significant factors propelling the market growth. For instance, according to the estimates of the National Cancer Institute, around 1,806,590 new cases were estimated to be diagnosed in the U.S. in 2020.

In addition, the COVID-19 pandemic has impacted the market for endoscopes. The postponement of elective surgeries and the reduction in the number of elective surgeries performed during the pandemic have drastically impacted the market. In addition, changing regulations with a view to curtailing the infection due to virus, along with the disruptions in the supply chain, have hampered the market growth during the pandemic. For instance, according to a 2020 multicenter survey from Northern Italy, published in the American Gastroenterological Association (AGA), a reduction of 97.6% was experienced in endoscopy units with COVID-19 positive patients.

Request a free sample copy or view report summary: Endoscopes Market Report

Endoscopes Market Report Highlights

• By product, the flexible endoscopes segment held the largest revenue share in 2020 owing to the growing preference for such devices among medical professionals, technological advancements, increased efficiency and safety, and ergonomic features of the flexible endoscopes
• Based on application, the gastrointestinal (GI) endoscopy segment dominated the market in 2020 owing to the growing geriatric population and the rising burden of gastrointestinal diseases
• In terms of end use, hospitals accounted for the largest revenue share in 2020 owing to favorable reimbursement policies and large adoption and utilization of endoscopes in hospital systems
• North America dominated the market with a revenue share of 42.5% in 2020 owing to various factors including the improved healthcare infrastructure, the rising adoption of advanced technologies, and the growing preference for minimally invasive surgeries to curb healthcare spending

Access Press Release of Endoscopes Market @ https://www.grandviewresearch.com/press-release/global-endoscopes-market

Endoscopes Market Segmentation

Grand View Research has segmented the global endoscopes market based on product, application, end-use, and region:

Endoscopes Product Outlook (Revenue, USD Million, 2016 - 2028)

• Rigid Endoscopes
  • Laparoscopes
  • Arthroscopes
  • Urology Endoscopes
  • Cystoscopes
  • Gynecology Endoscopes
  • Neuroendoscopes
  • Other Rigid Endoscopes
• Flexible Endoscopes
  • Upper Gastrointestinal Endoscopes
  • Colonoscopes
  • Bronchoscopes
  • Sigmoidoscopes
  • Laryngoscopes
  • Pharyngoscopes
  • Duodenoscopes
  • Nasopharyngoscopes
  • Rhinoscopes
  • Other Flexible Endoscopes
• Capsule Endoscopes
• Disposable Endoscopes
• Robot Assisted Endoscopes

Endoscopes Application Outlook (Revenue, USD Million, 2016 - 2028)

• Gastrointestinal (GI) Endoscopy
• Laparoscopy
• Obstetrics/Gynecology Endoscopy
• Arthroscopy
• Urology Endoscopy (Cystoscopy)
• Bronchoscopy
• Mediastinoscopy
• Otoscopy
• Laryngoscopy
• Other Applications

Endoscopes End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgery Centers/Clinics
• Other End Uses

Endoscopes Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Switzerland
  • Denmark
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Thailand
  • Indonesia
  • Malaysia
  • Vietnam
  • Philippines
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Israel
  • Qatar

List of Key Players of Endoscopes Market

• Olympus Corporation
• PENTAX Medical
• Ethicon US, LLC
• FUJIFILM Holdings Corporation
• Stryker
• Boston Scientific Corporation
• CONMED Corporation
• Karl Storz GmbH & Co., KG
• Richard Wolf Medical Instruments
• Medtronic

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Deep Brain Stimulation Devices Market to Observe Strong Development by 2028

 Deep Brain Stimulation Devices Market Growth & Trends

The global deep brain stimulation devices market size is anticipated to reach USD 2.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.3% from 2021 to 2028. Surge in incidence of neurological disorders, growing awareness about the deep brain stimulation devices and introduction of technologically advanced productsis attributing to the growth of market.

The incidence of neurological disorders such as Parkinson's disease, epilepsy, and depression is increasing globally, which is anticipated to positively impact the market growth. For instance, according to Depression and Bipolar Support Alliance, around 17.3 million adults in the U.S. are suffering from major depressive disorder. Thus, large number of people suffering from such conditions and disorders is expected to boost market growth during the forecast period.

Potential benefits of Deep Brain Stimulation (DBS) devices such as long-term benefits and better postoperative outcomes, are anticipated to fuel the market growth. Additionally, these advancements help clinical researchers in investigational efficacy studies for the inclusion of DBS devices in the treatment of other neurological disorders. Such factors are expected to raise the demand for DBS devices over the forecast period.

Request a free sample copy or view report summary: Deep Brain Stimulation Devices Market Report

Deep Brain Stimulation Devices Market Report Highlights

• On the basis of product, the dual channel segment dominated the market in 2020 with the share of 57.2%. Growing adoption of double-channel DBS devices for treatment of numerous neurological disorders, such as PD, dystonia, Alzheimer’s, and epilepsy driving the segment
• Based on application, the Parkinson’s disease segment dominated the market in 2020 with the share of 65.2% owing to rising prevalence of PD globally. According to UCB report, around 100,000 people in Canada are living with PD at present and more than 6,600 new cases are diagnosed each year
• In the end-use segment, hospitals dominated the market in 2020 and accounted for the largest revenue share of 52.0% owing to increase in number of DBS surgeries performed in hospitals and surge in prevalence of neurological disorders
• North America dominated the market with the highest revenue share of 51.9% in 2020. This is due high prevalence of psychological disorders, availability of highly skilled physicians, and rise in awareness about treatments in this continent

Deep Brain Stimulation Devices Market Segmentation

Grand View Research has segmented the global Deep Brain Stimulation devices market on the basis of product, application, end use, and region:

Deep Brain Stimulation Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Single Channel
• Dual Channel

Deep Brain Stimulation Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• Pain Management
• Epilepsy
• Essential Tremor
• Obsessive-compulsive Disorder (OCD)
• Depression
• Dystonia
• Parkinson’s Disease
• Others

Deep Brain Stimulation Devices End-use (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Neurology Clinics
• Ambulatory Surgical Centers
• Research Centers

Deep Brain Stimulation Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Sweden
  • Ireland
  • Poland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Thailand
  • Philippines
  • Malaysia
  • Singapore
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Venezuela
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Iran

List of Key Players of Deep Brain Stimulation Devices Market

• Abbott (St. Jude Medical)
• Medtronic
• Boston Scientific Corporation
• Aleva Neurotherapeutics S.A.
• Nexstim
• LivaNova PLC
• Neuropace Inc.

Access Press Release of Deep Brain Stimulation Devices Market @ https://www.grandviewresearch.com/press-release/global-deep-brain-stimulators-dbs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Digital Pathology Market Size Is Expected To Reach USD 1.5 Billion by 2028

 Digital Pathology Market Growth & Trends

The global digital pathology market size is expected to reach USD 1.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.8% from 2021 to 2028. The increasing prevalence of chronic diseases triggers the demand for advanced diagnostics, which is expected to drive market growth. Growing economic stability and awareness pertaining to the benefits of using Computer-Aided Diagnostics (CAD) is further contributing to the growth.

Moreover, supportive regulations amidst COVID-19 pandemic is anticipated to increase penetration of digital pathology system in coming years. A March 2020 memorandum issued by the CMS stated that laboratories would be allowed to utilize temporary testing sites, such as homes, for digital pathology review and reporting, even if they are not CLIA-certified (provided that certain criteria are met). This waiver gives pathology labs the necessary regulatory flexibility to remotely maintain operations during the pandemic.

During the pandemic, interim extraordinary measures were put in place in relation to Medical Device Single Audit Program (MDSAP) audits. These allowed substitutions of on-site audits with alternative arrangements, such as desktop audit, remote audit, hybrid audit, and surrogate audit. In July 2020, Proscia received MDSAP certification.

Digital pathology has an important role in companion diagnostics and drug development pipeline, including molecular biology, biobanking, molecular tissue profiling, and tissue microarray analysis. Increasing demand for high-quality tissue samples in tissue-based biomarker research is expected to propel the adoption of the technology over the forecast period.

Request a free sample copy or view report summary: Digital Pathology Market Report

Digital Pathology Market Report Highlights

• Devices held the dominant market share in 2020 owing to increased use in academic research
• The rising implementation of slide management system in stratified medicine and tissue-based biomarker research is one of the key contributing factors for the dominance of this technology
• The software segment is expected to witness lucrative growth in the near future as the product assists in faster diagnosis and synchronization of patient data, where healthcare professionals can remotely access this information
• Digital pathology is increasingly used in academic research owing to various benefits, such as cost-effectiveness and rapid results
• The disease diagnosis segment is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of cancer and demand for noble diagnosis techniques
• The availability of unified platforms for workflows in pathology is anticipated to boost the usage of computer-aided imaging technology in academic research, which is anticipated to boost segment growth
• Hospitals led the end-use segment in 2020 owing to the increasing adoption of digital pathology
• The market is expected to remain innovation-led, with frequent acquisitions and strategic alliances. New product development and well-established distribution channels are key to the competitive advantage of leading players
• An increasing usage rate of the digital imaging systems to facilitate faster diagnosis, particularly of chronic diseases; the increased uptake of these products serves as the key driver of this market

Digital Pathology Market Segmentation

Grand View Research has segmented the global digital pathology market on the basis of product, application, end-use, and region:

Digital Pathology Product Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Device
• Storage System

Digital Pathology Application Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Discovery & Development
• Academic research
• Disease Diagnosis

Digital Pathology End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Biotech & pharma companies
• Diagnostic Labs
• Academic & research institutes

Digital Pathology Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Thailand
  • Australia
  • South Korea
  • Philippines
  • Malaysia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • Saudi Arabia
  • South Africa
  • Turkey
  • Iran
  • United Arab Emirates
  • Israel

List of Key Players of Digital Pathology Market

• Danaher
• Hamamatsu Photonics, Inc
• Koninklijke Philips N.V.
• Olympus Corporation
• Hoffmann-La Roche Ltd
• Mikroscan Technologies
• Inspirata, Inc
• Visiopharm A/S
• Huron Digital Pathology
• 3DHISTECH Ltd.
• ContextVision AB

Access Press Release of Digital Pathology Market @ https://www.grandviewresearch.com/press-release/global-digital-pathology-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand Surgical Equipment Market Increasing in Most Part of World 2028

 Surgical Equipment Market Growth & Trends

The global surgical equipment market size is anticipated to reach USD 24.5 billion by 2028 registering a CAGR of 9.8%, according to a new report by Grand View Research, Inc. Developing surgical care infrastructure, the advent of minimally invasive surgical techniques, and increasing cases of cesarean deliveries are the factors contributing significantly to the growth of this market. An increasing number of hospital visits for surgeries, such as hip and knee replacement, hernia repair, gall bladder removal, and other urology ailments, is also anticipated to propel the market growth during the forecast period.

According to the National Joint Registry report published in 2018, the number of knee replacement procedures performed in the U.K. reached 102,177 in 2017 from 81,590 in 2014. Lump-sum payment pertaining to specialty surgical services paired with out-of-pocket-based healthcare in many middle-income countries is expected to restrain the market growth during the forecast period. According to the global surgery 2030 report, each year over 33 million individuals have to face catastrophic expenditure. In addition, due to the limitation of resources, such as personal protective equipment, surgical staff, OR rooms, inpatient beds, and blood products, the surgery appointment for many non-emergent patients was postponed during the pandemic.

This has negatively impacted the sales of surgical equipment in 2020. According to the Healthcare Financial Management Association report, in the U.S. the cancellation and rescheduling rate of elective surgeries in the period of April-July 2020 was approximately 50%. However, currently, with several countries lifting bans on elective surgeries and clinics resuming their surgical services, the demand for surgical equipment, especially single-use devices, is expected to rise driving the market growth.

Request a free sample copy or view report summary: Surgical Equipment Market Report

Surgical Equipment Market Report Highlights

• The surgical sutures & staplers product segment held the largest market share in 2020 and will expand further at a steady CAGR from 2021 to 2028
• This growth is attributed to technological advancements, such as drug-eluting sutures and absorbable staples
• The electrosurgical devices segment is anticipated to register the fastest CAGR of 11.2% during the forecast period
• The obstetrics & gynecology application segment accounted for the largest revenue share in 2020
• However, plastic & reconstructive is estimated to be the fastest-growing application segment at a CAGR of 11.0% over the forecast period
• North America was the leading regional market in 2020 as the U.S. is one of the major suppliers of surgical equipment globally
• The Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to high unmet surgical needs in emerging economies

Surgical Equipment Market Segmentation

Grand View Research has segmented the global surgical equipment market on the basis of product, application, and region:

Surgical Equipment Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Surgical Sutures & Staplers
• Handheld Surgical Devices
  • Forceps & Spatulas
  • Retractors
  • Dilators
  • Graspers
  • Auxiliary Instruments
  • Cutter Instruments
  • Others
• Electrosurgical Devices

Surgical Equipment Application Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Neurosurgery
• Plastic & Reconstructive Surgery
• Wound Closure
• Obstetrics & Gynecology
• Cardiovascular
• Orthopedic
• Others

Surgical Equipment Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Surgical Equipment Market

• Smith & Nephew plc
• Zimmer Biomet Holdings, Inc.
• Braun Melsungen AG
• Medtronic PLC
• Stryker Corporation
• Ethicon, Inc.
• Aspen Surgical Products, Inc.
• Alcon Laboratories, Inc.

Access Press Release of Surgical Equipment Market @ https://www.grandviewresearch.com/press-release/global-surgical-equipment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Trials Market Witness Excellent Revenue Growth During 2021-2028: Grand View Research Inc

 Clinical Trials Market Growth & Trends

The global clinical trials market size is expected to reach USD 69.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2021 to 2028. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and other products. Also, clinical studies have become increasingly costly ventures, adding to the overall cost of developing a drug. Hence, big pharmaceuticals as well as small biotechnology firms are looking for innovative ways to improve research outcomes and decrease research costs.

The increasing need to develop new therapeutics for chronic diseases such as cancer, respiratory disorder, diabetes, cardiovascular disease, and others is creating immense pressure on healthcare. The global pandemic caused due to COVID-19 and the increasing demand for developing a suitable treatment for the same is driving the market’s growth. The number of people affected by the coronavirus has reached one million, which further depicts an increasing need for therapeutics and vaccines. Currently, there are 288 therapeutics and 106 vaccines in development. Out of this, nearly 7.0% therapeutics are in Phase IV, 21.0% in Phase III, 43.0% & 13.0% in Phase II & Phase I respectively.

The pandemic has also resulted in global disruption of traditional onsite clinical studies. Hence, the regulatory bodies all over the world have launched various initiatives for fast-tracking clinical studies for the development of innovative solutions. One such instance is Solidarity, an international clinical trial launched by the WHO to find effective treatment against COVID-19.

Though COVID-19 is forcing many medical device and drug developers to revise the approach they prepare for these types of crises, integrating best practices within clinical trial procedures and adapting to virtual studies can support continuous development of therapeutics even in the presence of this pandemic.

Request a free sample copy or view report summary: Clinical Trials Market Report

Clinical Trials Market Report Highlights

• Phase III clinical trials dominated the market with a share of 53.2% in 2020. This is attributed to the complexity level associated with this phase
• Interventional design segment accounted for the largest share of 45.6% in 2020 in the study design segment owing to the increasing demand for the intervention for clinical studies by researchers
• North America held 51.0% of the market share in 2020. Favorable government initiatives and presence of large numbers of players in the U.S. offerings advanced services are responsible for market growth
• In Asia Pacific, the market is expected to witness the fastest CAGR of 6.7% over the forecast period owing to the increasing patient pool and cost efficient services

Clinical Trials Market Segmentation

Grand View Research has segmented the global clinical trials market based on phase, study design, indication, and region:

Clinical Trials Phase Outlook (Revenue, USD Million, 2016 - 2028)

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trials Study Design Outlook (Revenue, USD Million, 2016 - 2028)

• Interventional
• Observational
• Expanded Access

Clinical Trials Indication Outlook (Revenue, USD Million, 2016 - 2028)

• Autoimmune/Inflammation
• Pain management
• Oncology
• CNS condition
• Diabetes
• Obesity
• Cardiovascular
• Others

Clinical Trials Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Clinical Trials Market

• IQVIA
• PAREXEL International Corporation
• Pharmaceutical Product Development, LLC
• Charles River Laboratory
• ICON Plc
• PRA Health Sciences
• Syneos Health
• Eli Lilly and Company
• Novo Nordisk A/S
• Pfizer
• Clinipace

Access Press Release of Clinical Trials Market @ https://www.grandviewresearch.com/press-release/clinical-trials-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Contract Research Organization Market will be Worth USD 66.1 Billion by 2028: Grand View Research Inc.

 Healthcare CRO Market Growth & Trends

The global healthcare contract research organization market size is expected to reach USD 66.1 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The increasing cost of drug development is expected to drive the market over the forecast period. Moreover, rising clinical trial cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations (CROs). Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure and expertise and minimize their cost and timelines.

However, the CRO market has been significantly impacted by the ongoing pandemic. The worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of other vaccines and drugs. At the peak of the pandemic, vaccines and treatments for COVID-19 accounted for 30% of all the trials in the U.S. This resulted in other trials being put on hold.

The CRO market is recovering slowly through a hybrid approach. They are playing a significant role in helping sponsors and sites to start clinical trials. Market players have already built powerful tools to support virtual clinical trials. They are ready to rapidly assist sponsors to shift to this new environment and leverage the available tools.

Request a free sample copy or view report summary: Healthcare CRO Market Report

Healthcare CRO Market Report Highlights

• Based on type, clinical trial services dominated the global market in 2020 and held a share of 76.7% owing to the fact that it comprises four elaborate phases, including human subjects
• By service, the clinical monitoring segment held the largest revenue share in 2020
• North America held a significant share in 2020 due to the presence of several global players, who invest a major part of their revenue in research activities
• Asia Pacific is anticipated to register the fastest CAGR over the forecast period due to the reduced cost it offers in comparison to the U.S. and other developed economies. China, Japan, and India are projected to witness tremendous growth in the contract research organization market owing to high disease prevalence

Healthcare CRO Market Segmentation

Grand View Research has segmented the global healthcare contract research organization market based on type, service, and region:

Healthcare CRO Type Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Discovery
  • Target Validation
  • Lead Identification
  • Lead Optimization
• Pre-clinical
• Clinical
  • Phase I Trial Services
  • Phase II Trial Services
  • Phase III Trial Services
  • Phase IV Trial Services

Healthcare CRO Service Outlook (Revenue, USD Million, 2016 - 2028)

• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient and Site Recruitment
• Technology
• Others

Healthcare CRO Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Switzerland
  • Belgium
  • Netherlands
  • Austria
• Asia Pacific
  • India
  • China
  • Japan
  • Korea (Republic)
  • Taiwan
  • Australia
  • Indonesia
  • Malaysia
  • Singapore
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Iran
  • Israel

List of Key Players of Healthcare CRO Market

• IQVIA
• Covance
• Pharmaceutical Product Development, LLC (PPD)
• PAREXEL International Corporation
• Charles River Laboratories (CRL)
• ICON plc
• Medidata Solutions
• Syneos Health
• Pharmaron
• GVK Biosciences Private Limited

Access Press Release of Healthcare Contract Research Organization Market @ https://www.grandviewresearch.com/press-release/global-healthcare-cro-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Revenue Cycle Management Market Size Is Anticipated To Reach $633.6 Billion by 2028

 

Revenue Cycle Management Market Growth & Trends

The global revenue cycle management market size is projected to reach USD 633.6 billion by 2028, according to a new report by Grand View Research, Inc. This market is expected to expand at a CAGR of 11.5% from 2021 to 2028. Increasing technological advancements and rising adoption of revenue cycle management (RCM) tools by various healthcare providers and others have led to development and upgradation of solutions provided by key players are the major factors driving the market.

The integrated type emerged as the largest segment and accounted for significant revenue share of 69.6% in 2020. Integrated solutions provide a coordinated and streamlined format of a variety of financial activities via a single platform, which results in a uniform process of data collection and analysis. Hence, rising adoption of integrated systems is likely to fuel the growth during the forecast period.

Based on product, the software segment is predicted to account for the largest market share valued at USD 159.9 billion in 2020. The growth of the segment is owing to rising adoption and penetration of software-based solutions in the revenue cycle management sector. On the other hand, the service segment is projected to be the fastest-growing segment over the forecast period, owing to the demand of outsourcing services due to the sudden outbreak of the COVID-19 pandemic.

On the basis of delivery mode, the web-based segment dominated the market with the highest revenue share in 2020. Key factors responsible for the augmenting growth are rising installation of integrated solutions, and enhanced accessibility. On the other hand, the cloud-based segment is expected to witness the fastest CAGR over the forecast period.

North America dominated the market in 2020 with the highest revenue share of 52.6%. Strong healthcare infrastructure, government initiatives boosting adoption of RCM solutions, and rising consolidation between vendors offering RCM solutions are some of the major factors driving the demand of RCM tools and services in this region. On the other hand, Asia Pacific is anticipated to be the fastest-growing region during the forecast period. Fast growing economies like South Korea, Singapore, and Australia are investing in RCM healthcare solutions to improve the billing procedures and claim settlements in rural areas which is expected to surge the growth of the RCM services in the region over the forecast period.

Request a free sample copy or view report summary: Revenue Cycle Management Market Report

Revenue Cycle Management Market Report Highlights

• The market was valued at USD 261.8 Billion in 2020 and is anticipated to witness a CAGR of 11.5% over the forecast period
• The software segment accounted for the largest revenue share valued at USD 159.9 billion in 2020 owing to the growing market penetration of software-based solutions in the RCM sector
• In 2020, integrated segment accounted for the largest revenue share of 69.6% owing to the rising need to improve the efficiency of healthcare systems and curtail healthcare costs
• The web-based delivery mode segment dominated the market in 2020 in terms of revenue share

Revenue Cycle Management (RCM) Market Segmentation

Grand View Research has segmented the global revenue cycle management market based on product, type, delivery mode, end-use, and region:

RCM Product Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Services

RCM Type Outlook (Revenue, USD Million, 2016 - 2028)

• Integrated
• Standalone

RCM Delivery Mode Outlook (Revenue, USD Million, 2016 - 2028)

• On-premise
• Web-based
• Cloud based

RCM End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Physician Offices
• Hospitals
• Diagnostic Laboratories
• Others

RCM Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • Singapore
  • South Korea
  • Australia
• Latin America
  • Mexico
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Revenue Cycle Management (RCM) Market

• The SSI Group, Inc.
• AllScripts Healthcare, LLC
• Experian Health, R1 RCM Inc.
• McKesson Corporation
• athenahealth, Inc.
• Epic Systems Corporation
• NXGN Management, LLC
• CareCloud Corporation
• Quest Diagnostics, Inc.
• R1 RCM Inc.

Access Press Release of Revenue Cycle Management Market @ https://www.grandviewresearch.com/press-release/global-revenue-cycle-management-rcm-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Waterproofing Membranes Market Exhibit a Steady 7.5% CAGR through 2028: Grand View Research Inc.

Waterproofing Membranes Market Growth & Trends

The global waterproofing membranes market size is expected to reach USD 37.18 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.5% from 2021 to 2028. The growing advancement in infrastructure and construction activities, coupled with a rise in demand for wastewater and water management, is expected to drive the market.

Adoption of wastewater techniques for water conservation and reuse is increasing owing to the rising demand for portable water resources across the globe. In addition, increasing government support to promote and adopt a wide array of waste management and water treatment initiatives is expected to boost the demand for the product during the forecast period.

Biomembranes are expected to witness a high adoption trend in the coming future owing to the increasing product demand in green building construction. In addition, government support to replace old buildings with new ones is opening new growth avenues for the construction industry, in turn, adding growth to the overall market.

The market is highly dependent upon the dynamics of the raw material supply chain. Although all types of products including cementitious, bituminous, and polyurethane are used for manufacturing waterproofing membranes, cementitious liquid applied membrane and bituminous sheet membranes are the most commonly used waterproofing membranes in the market.

The industry exhibits several mature players controlling a significant market share. However, increasing competition from a large number of small and local manufacturers from the Asia Pacific region is expected to boost the market competition. The market players put high stress on using sustainable raw materials to ensure an environmentally friendly image to their clients.

Request a free sample copy or view report summary: Waterproofing Membranes Market Report

Waterproofing Membranes Market Report Highlights

• By product, liquid applied membranes are expected to register the fastest revenue-based CAGR from 2021 to 2028 on account of their thermal-reflective properties for any exterior surface application
• Polyurethane liquid applied waterproofing membranes are expected to expand at the fastest revenue-based CAGR of 9.5% during the forecast period owing to seamless finish and easy and fast installation procedure
• The roofing application segment accounted for the largest revenue share of over 31.0% in 2020 owing to its high exposure to changing climatic conditions and leakages across residential, commercial, and industrial buildings
• Asia Pacific is projected to register the fastest CAGR in terms of revenue owing to increasing investment in residential and commercial construction due to rapid industrialization and the growing population
• The majority of the manufacturers have started emphasizing the use of sustainable and corrosive protective raw materials for producing waterproofing membranes to increase their market presence. In addition, growing infrastructure in the developing markets of China, India, and Brazil is adding rapid growth to the construction sector, thereby offering growth prospects to the market

Waterproofing Membranes Market Segmentation

Grand View Research has segmented the global waterproofing membranes market on the basis of product, application, and region:

Waterproofing Membrane Product Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• Liquid Applied Membranes
  • Cementitious
  • Bituminous
  • Polyurethane
  • Acrylic
  • Others
• Sheet Membranes
  • Bituminous
  • Polyvinyl Chloride (PVC)
  • Ethylene Propylene Diene Monomer (EPDM)
  • Others

Waterproofing Membrane Application Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• Roofing
• Walls
• Building Structures
• Landfills & Tunnels
• Others

Waterproofing Membrane Regional Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players of Waterproofing Membranes Market

• BASF SE
• Kemper System America, Inc.
• GAF Materials Corporation
• Paul Bauder GmbH & Co. KG
• CICO Technologies Ltd.
• Fosroc Ltd.
• DuPont

Access Press Release of Waterproofing Membranes Market@ https://www.grandviewresearch.com/press-release/waterproofing-membranes-market

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Defibrillator Market Projected to Discern Stable Expansion by 2028

 Defibrillator Market Growth & Trends

The global defibrillator market size is expected to reach USD 22.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. Factors contributing to the growth of this market include supportive legislative reforms, rising incidences of sudden cardiac arrests in the region, presence of integrated technology, and rising awareness for cardiac conditions. Moreover, the COVID 19 pandemic further accentuated the need for defibrillators as many elderly patients suffering from COVID-19, suffered from sudden cardiac arrests, and the device was useful for the resuscitation of such patients.

The rising demand for handling sudden cardiac arrests is leading to innovation in implantable as well as external defibrillators. Innovation with regards to implantable devices includes subcutaneous and transvenous devices, that aim to increase the comfort level of patients. Swedish Transport Agency ran a program in 2017 under the test phase, which aimed to deliver AEDs using a drone. This may reduce the delivery time of an AED, increasing the chances of survival with faster treatment. Therefore, the market is anticipated to grow because of technological advancements and product delivery innovations.

Major market players are focused on launching technologically advanced products to enhance their presence. For instance, in July 2020, Zoll Medical Corporation launched a new remote view technology feature on its X Series monitor/defibrillator. This enhanced the existing product portfolio.

Request a free sample copy or view report summary: Defibrillator Market Report

Defibrillator Market Report Highlights

• The implantable cardioverter defibrillator segment dominated the market in terms of revenue share in 2020 and is projected to witness a CAGR of over 7.2% from 2021 to 2028. Technological advancements by market players are expected to drive segment growth
• North America held the largest revenue share in 2020, due to the supportive healthcare infrastructure and deeper penetration of the technologically advanced devices
• The industry participants are focusing on investing in acquisitions, collaborations, product launches, and partnerships to gain a competitive edge
• The hospital segment held the largest revenue share of more than 91.0% in 2020 owing to the high patient footfall for treatment of their cardiovascular ailments
• In Asia Pacific, the market is anticipated to witness a CAGR of around 8.1% owing to the presence of emerging economies such as China and India and increasing healthcare expenditure
• In January 2020, Medtronic received the CE mark for its Crome and Cobalt portfolio of defibrillators. This significantly enhanced the company’s cardiac solutions offerings and allowed it to commercialize the products in the market

Defibrillator Market Segmentation

Grand View Research has segmented the global defibrillator market on the basis of product, end-use, and region:

Defibrillators Product Outlook (Revenue, USD Million, 2016 - 2028)

• Implantable Cardioverter Defibrillator
  • S-ICD
  • T-ICD
    • Single Chamber
    • Dual Chamber
    • CRT-D
  • External Defibrillator
    • Manual ED
    • Automated ED
    • Wearable Cardioverter Defibrillators

Defibrillators End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital
• Pre Hospital
• Public Access market
• Alternate Care market
• Home Healthcare

Defibrillators Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Defibrillator Market

• Medtronic
• Abbott
• Boston Scientific Corporation
• Stryker
• Koninklijke Philips N.V.
• Zoll Medical Corporation
• Biotronik, Inc.
• Nihon Kohden Corporation
• Progetti Srl, Schiller
• MS Westfalia GmbH
• AMI Italia
• Axion Ltd
• Bexen Cardio

Access Press Release of Defibrillator Market@ https://www.grandviewresearch.com/press-release/global-defibrillators-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.